<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.dermatologytimes.com/view/bioelements-and-celluma-collaborate-on-led-facial-treatments</loc>
      <lastmod>2026-11-17T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Bioelements and Celluma Collaborate on LED Facial Treatments]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/alopecia-areata-patient-advice-treatment-decisions-choosing-a-specialist-and-self-advocacy</loc>
      <lastmod>2026-11-17T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Alopecia Areata Patient Advice: Treatment Decisions, Choosing a Specialist, and Self-Advocacy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/interpreting-gep-results-in-melanoma-limitations-and-patient-centered-care</loc>
      <lastmod>2026-11-17T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Interpreting GEP Results in Melanoma: Limitations and Patient-Centered Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/monitoring-and-treatment-selection-for-oral-tyk2-inhibitors-in-psoriasis</loc>
      <lastmod>2026-11-16T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Monitoring and Treatment Selection for Oral TYK2 Inhibitors in Psoriasis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/fda-implements-updated-ipledge-rems-requirements-for-isotretinoin</loc>
      <lastmod>2026-11-16T19:49:32.572Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T19:49:32.572Z</news:publication_date>
        <news:title><![CDATA[FDA Implements Updated iPLEDGE REMS Requirements for Isotretinoin]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/aclaris-bosakitug-misses-phase-2-endpoints-in-atopic-dermatitis</loc>
      <lastmod>2026-11-16T14:36:45.580Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T14:36:45.580Z</news:publication_date>
        <news:title><![CDATA[Aclaris' Bosakitug Misses Phase 2 Endpoints in Atopic Dermatitis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.dermatologytimes.com/view/journal-digest-november-16</loc>
      <lastmod>2026-11-16T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Dermatology Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Journal Digest: November 16]]></news:title>
      </news:news>
	</url></urlset>